Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance (original) (raw)

Nature Medicine volume 12, pages 650–656 (2006)Cite this article

Abstract

Here we report the presence of hyperphagia, obesity and insulin resistance in knockout mice deficient in IL-18 or IL-18 receptor, and in mice transgenic for expression of IL-18 binding protein. Obesity of _Il18_−/− mice resulted from accumulation of fat tissue based on increased food intake. Il18 −/− mice also had hyperinsulinemia, consistent with insulin resistance and hyperglycemia. Insulin resistance was secondary to obesity induced by increased food intake and occurred at the liver level as well as at the muscle and fat-tissue level. The molecular mechanisms responsible for the hepatic insulin resistance in the Il18 −/− mice involved an enhanced expression of genes associated with gluconeogenesis in the liver of Il18 −/− mice, resulting from defective phosphorylation of STAT3. Recombinant IL-18 (rIL-18) administered intracerebrally inhibited food intake. In addition, rIL-18 reversed hyperglycemia in Il18 −/− mice through activation of STAT3 phosphorylation. These findings indicate a new role of IL-18 in the homeostasis of energy intake and insulin sensitivity.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Joosten, L.A. et al. An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J. Immunol. 165, 6553–6558 (2000).
    Article CAS Google Scholar
  2. Netea, M.G. et al. Neutralization of interleukin-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J. Immunol. 164, 2644–2649 (2000).
    Article CAS Google Scholar
  3. Dinarello, C.A. IL-18: A Th1-inducing, proinflammatory cytokine and a new member of the IL-1 family. J. Allergy Clin. Immunol. 103, 11–24 (1999).
    Article CAS Google Scholar
  4. Ghayur, T. et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386, 619–623 (1997).
    Article CAS Google Scholar
  5. Novick, D. et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10, 127–136 (1999).
    Article CAS Google Scholar
  6. Moriwaki, Y. et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52, 605–608 (2003).
    Article CAS Google Scholar
  7. Escobar-Morreale, H.F., Botella-Carretero, J.I., Villuendas, G., Sancho, J. & San Millan, J.L. Serum interleukin-18 concentrations are increased in the plycystic ovary syndrome: relationship to insulin resistance and obesity. J. Clin. Endocrinol. Metab. 89, 806–811 (2004).
    Article CAS Google Scholar
  8. Esposito, K. et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Circulation 106, 2067–2072 (2002).
    Article CAS Google Scholar
  9. Reaven, G.M. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu. Rev. Med. 44, 121–131 (1993).
    Article CAS Google Scholar
  10. Inoue, H. et al. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat. Med. 10, 168–174 (2004).
    Article CAS Google Scholar
  11. Blaskovich, M.A. et al. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 63, 1270–1279 (2003).
    CAS PubMed Google Scholar
  12. Ishibashi, S., Goldstein, J.L., Brown, M.S., Herz, J. & Burns, D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93, 1885–1893 (1994).
    Article CAS Google Scholar
  13. Gao, Q. et al. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc. Natl. Acad. Sci. USA 101, 4661–4666 (2004).
    Article CAS Google Scholar
  14. Bjorbaek, C., El-Haschimi, K., Frantz, D.F. & Flier, J.S. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274, 30059–30065 (1999).
    Article CAS Google Scholar
  15. Ueki, K., Kondo, T., Tseng, Y.H. & Kahn, C.R. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl. Acad. Sci. USA 101, 10422–10427 (2004).
    Article CAS Google Scholar
  16. Pocai, A. et al. Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes 54, 3182–3189 (2005).
    Article CAS Google Scholar
  17. Kalina, U. et al. IL-18 activates STAT3 in the Natural Killer cell line 92, augments cytotoxic activity, and mediates IFN production by the stress kinase p38 and by the extracellular regulated kinases p44/erk-1 and p42/erk-21. J. Immunol. 165, 1307–1313 (2000).
    Article CAS Google Scholar
  18. Gorogawa, S. et al. Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knock-out mice. Biochem. Biophys. Res. Commun. 319, 1159–1170 (2004).
    Article CAS Google Scholar
  19. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18-mediated function. Immunity 9, 143–150 (1998).
    Article CAS Google Scholar
  20. Yamauchi, T. et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941–946 (2001).
    Article CAS Google Scholar
  21. Takeda, K. et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8, 383–390 (1998).
    Article CAS Google Scholar
  22. Smith, S.J. et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat. Genet. 25, 87–90 (2000).
    Article CAS Google Scholar
  23. Miyake, K. et al. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J. Clin. Invest. 110, 1483–1491 (2002).
    Article CAS Google Scholar
  24. Voshol, P.J. et al. In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 50, 2585–2590 (2001).
    Article CAS Google Scholar
  25. Chomczynski, P. & Sacchi, N. Single step method of RNA isolation by acid guanidinum phenol chloroform extraction. Anal. Biochem. 162, 156–159 (1987).
    Article CAS Google Scholar

Download references

Acknowledgements

M.G.N. was supported by a Vidi grant from Netherlands Foundation of Scientific Research (NWO). P.J.V. was supported by Zon-MW Veni grant 916-36-071. We thank G. Fantuzzi for her help with the leptin-resistance experiments, and critically reading the manuscript.

Author information

Author notes

  1. Mihai G Netea and Leo A B Joosten: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Internal Medicine and Nijmegen University Center for Infectious Diseases, Geert Grooteplein 8, Nijmegen, 6500 HB, The Netherlands
    Mihai G Netea, Bart Jan Kullberg, Cees J Tack, Anton F Stalenhoef, Ineke Verschueren & Jos W M van der Meer
  2. Division of Infectious Diseases University of Colorado Health Sciences Center, 4200 East Ninth Avenue, B168, Denver, 80262, Colorado, USA
    Mihai G Netea, Eli Lewis & Charles A Dinarello
  3. Department of Rheumatology Research and Advanced Therapeutics, Nijmegen Center for Molecular Life Sciences, Radboud University Nijmegen Medical Center, Geert Grooteplein 22, Nijmegen, 6500 HB, The Netherlands
    Leo A B Joosten, Soo-Hyun Kim, Fons A van de Loo & Wim van den Berg
  4. Division of Endocrinology, Fitzsimmons Campus RC-1 South, Aurora, P.O. Box 6511, MS 8106, 80045, Colorado
    Dalan R Jensen, Leslie Pulawa & Robert H Eckel
  5. University of Colorado Health Sciences Center, USA
    Dalan R Jensen, Leslie Pulawa & Robert H Eckel
  6. Department of Endocrinology, Leiden University Medical Center, Albinusdreef 2, ZA Leiden, 2333, The Netherlands
    Peter J Voshol
  7. Department of Pathology, Radboud University Nijmegen Medical Center, Geert Grooteplein 10, HB Nijmegen, 6500, The Netherlands
    Han van Krieken
  8. Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Yamadaoka 3-1, Suita, Osaka, 565-0871, Japan
    Shizuo Akira

Authors

  1. Mihai G Netea
    You can also search for this author inPubMed Google Scholar
  2. Leo A B Joosten
    You can also search for this author inPubMed Google Scholar
  3. Eli Lewis
    You can also search for this author inPubMed Google Scholar
  4. Dalan R Jensen
    You can also search for this author inPubMed Google Scholar
  5. Peter J Voshol
    You can also search for this author inPubMed Google Scholar
  6. Bart Jan Kullberg
    You can also search for this author inPubMed Google Scholar
  7. Cees J Tack
    You can also search for this author inPubMed Google Scholar
  8. Han van Krieken
    You can also search for this author inPubMed Google Scholar
  9. Soo-Hyun Kim
    You can also search for this author inPubMed Google Scholar
  10. Anton F Stalenhoef
    You can also search for this author inPubMed Google Scholar
  11. Fons A van de Loo
    You can also search for this author inPubMed Google Scholar
  12. Ineke Verschueren
    You can also search for this author inPubMed Google Scholar
  13. Leslie Pulawa
    You can also search for this author inPubMed Google Scholar
  14. Shizuo Akira
    You can also search for this author inPubMed Google Scholar
  15. Robert H Eckel
    You can also search for this author inPubMed Google Scholar
  16. Charles A Dinarello
    You can also search for this author inPubMed Google Scholar
  17. Wim van den Berg
    You can also search for this author inPubMed Google Scholar
  18. Jos W M van der Meer
    You can also search for this author inPubMed Google Scholar

Contributions

M.G.N. and L.A.B.J. designed and performed the experiments, and wrote the manuscript. E.L. designed and performed the experiments, performed statistical analysis and edited the manuscript. D.R.J. and P.J.V. designed and performed experiments and edited the manuscript. B.J.K., C.J.T., A.F.S., R.H.E., C.A.D., W. vd B. and J.W.M. vd M. designed experiments and edited the manuscript. H.v.K., S.-H.K., F.A.v.d.L., I.V. and L.P. performed experiments and edited the manuscript. S.A. provided knockout mice and edited the manuscript.

Corresponding author

Correspondence toMihai G Netea.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

About this article

Cite this article

Netea, M., Joosten, L., Lewis, E. et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.Nat Med 12, 650–656 (2006). https://doi.org/10.1038/nm1415

Download citation